Afternoon Heart Surgery Linked to Better Patient Outcomes

Share this content:
Afternoon Heart Surgery Linked to Better Patient Outcomes
Afternoon Heart Surgery Linked to Better Patient Outcomes

FRIDAY, Oct. 27, 2017 (HealthDay News) -- For patients undergoing aortic valve replacement, perioperative myocardial injury occurs more with morning surgery than with afternoon surgery, according to a study published online Oct. 26 in The Lancet.

David Montaigne, M.D., from the University of Lille in France, and colleagues examined the incidence of major adverse cardiac events in a single-center prospective cohort study involving patients with severe aortic stenosis and preserved left ventricular ejection fraction who were referred for aortic valve replacement. Propensity-score-matched pairs of patients (298 pairs) underwent surgery in the morning or afternoon. The authors also examined perioperative myocardial injury and myocardial samples of 88 patients randomized to undergo isolated aortic valve replacement surgery in the morning or afternoon.

The researchers found that the incidence of major adverse cardiac events was lower in the afternoon group than the morning group (hazard ratio, 0.5) during the 500 days after aortic valve replacement. In the randomized study, the geometric mean of perioperative cardiac troponin T release was significantly lower in the afternoon versus the morning group (estimated ratio of geometric means, 0.79). An intrinsic afternoon-morning variation was seen in hypoxia-reoxygenation tolerance in ex-vivo analysis of human myocardium; the nuclear receptor Rev-Erbα was highest in the morning. In a mouse model, Rev-Erbα gene deletion or antagonist treatment reduced injury at the sleep-to-wake transition.

"Afternoon surgery might provide perioperative myocardial protection and lead to improved patient outcomes compared with morning surgery," the authors write.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell ...

Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma

ASH: AAVD Beats ABVD for Advanced Hodgkin's Lymphoma

ASH: A+AVD Beats ABVD for Advanced Hodgkin's Lymphoma

Lower combined risk of progression, death, or noncomplete response with A+AVD

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia A

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia ...

Factor VIII gene transfer tied to sustained normalization of factor VIII activity levels

is free, fast, and customized just for you!

Already a member?

Sign In Now »